MORINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.102
EU - Europa 1.095
AS - Asia 438
AF - Africa 22
OC - Oceania 1
Totale 2.658
Nazione #
US - Stati Uniti d'America 1.078
CN - Cina 343
FI - Finlandia 321
SE - Svezia 240
IE - Irlanda 205
UA - Ucraina 135
DE - Germania 120
TR - Turchia 54
SG - Singapore 33
GB - Regno Unito 27
CA - Canada 24
CI - Costa d'Avorio 22
BE - Belgio 19
IT - Italia 17
IN - India 5
AT - Austria 4
CZ - Repubblica Ceca 3
IR - Iran 3
AU - Australia 1
EE - Estonia 1
ES - Italia 1
FR - Francia 1
NL - Olanda 1
Totale 2.658
Città #
Chandler 222
Dublin 205
Jacksonville 187
Ann Arbor 108
Dearborn 86
Beijing 58
Nanjing 58
Izmir 54
New York 52
Ashburn 50
Shanghai 40
Princeton 37
San Mateo 29
Toronto 23
Abidjan 22
Jinan 21
Brussels 19
Hebei 19
Bremen 18
Wilmington 18
Hefei 17
Nanchang 17
Des Moines 15
Shenyang 13
Boardman 12
Grafing 12
Singapore 12
Kunming 11
Helsinki 10
Tianjin 10
Changsha 9
Houston 9
Seattle 8
Guangzhou 7
Los Angeles 7
Woodbridge 7
Haikou 6
Jiaxing 6
Hangzhou 5
Norwalk 5
Taiyuan 4
Vienna 4
Auburn Hills 3
Augusta 3
Brno 3
Milan 3
Ningbo 3
Parma 3
Sabz 3
Zhengzhou 3
Borås 2
Dallas 2
Fremont 2
Fuzhou 2
Leipzig 2
Magdeburg 2
Pune 2
Baotou 1
Bari 1
Canberra 1
Charlotte 1
Chengdu 1
Chongqing 1
Dundee 1
Düsseldorf 1
Frankfurt am Main 1
Jinhua 1
La Canada Flintridge 1
Lanzhou 1
London 1
Madison 1
Madrid 1
Mountain View 1
Mumbai 1
Munich 1
New Delhi 1
Piacenza 1
Redmond 1
Stevenage 1
Taizhou 1
Tallinn 1
Turate 1
Wuhan 1
Xian 1
Totale 1.597
Nome #
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 102
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 101
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 93
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 90
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 84
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 82
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 81
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 79
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 76
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 75
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 75
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 73
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 72
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 71
Antiulcer long-term treatment in chronic ulcer rat 71
Cytokinin-like activity of N,N'-diphenylureas. N,N'-bis-(2,3-methylenedioxyphenyl)urea and N,N'-bis-(3,4-methylenedioxyphenyl)urea enhance adventitious root formation in apple rootstock M26 (Malus pumila Mill) 71
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 70
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 69
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 68
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 68
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 68
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 67
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 66
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 66
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 65
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 63
Pharmacological activities of two new histamine analogs 62
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 62
null 61
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 60
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 59
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 58
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 53
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 53
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 51
Synthesis and binding assays of H3-receptor ligands. 51
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 48
null 37
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 35
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 10
Totale 2.666
Categoria #
all - tutte 8.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020592 85 74 43 9 52 64 84 10 70 28 33 40
2020/2021278 5 41 19 8 40 1 33 1 65 5 58 2
2021/2022206 5 1 4 19 12 16 26 28 10 12 14 59
2022/2023815 100 98 59 53 79 92 17 45 241 5 20 6
2023/2024264 16 27 4 7 17 92 25 11 10 9 15 31
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 2.666